Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pharma-Bio Serv (PBSV) Non Operating Income (2016 - 2023)

Pharma-Bio Serv (PBSV) has disclosed Non Operating Income for 14 consecutive years, with $126985.0 as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Non Operating Income rose 336.55% year-over-year to $126985.0, compared with a TTM value of $628228.0 through Jul 2023, up 1426.66%, and an annual FY2022 reading of $13418.0, down 99.32% over the prior year.
  • Non Operating Income was $126985.0 for Q3 2023 at Pharma-Bio Serv, down from $192616.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $2.0 million in Q3 2021 and bottomed at -$53683.0 in Q3 2022.
  • Average Non Operating Income over 5 years is $167833.2, with a median of $48584.0 recorded in 2020.
  • The sharpest move saw Non Operating Income tumbled 136.9% in 2020, then skyrocketed 39988.62% in 2023.
  • Year by year, Non Operating Income stood at $57436.0 in 2019, then fell by 28.31% to $41178.0 in 2020, then plummeted by 96.82% to $1310.0 in 2021, then soared by 4639.08% to $62082.0 in 2022, then soared by 104.54% to $126985.0 in 2023.
  • Business Quant data shows Non Operating Income for PBSV at $126985.0 in Q3 2023, $192616.0 in Q2 2023, and $246545.0 in Q1 2023.